Literature DB >> 23636058

Blockade of programmed death-1 in young (New Zealand Black x New Zealand White)F1 mice promotes the suppressive capacity of CD4+ regulatory T cells protecting from lupus-like disease.

Maida Wong1, Antonio La Cava, Bevra H Hahn.   

Abstract

Programmed death-1 (PD-1) usually acts as a negative signal for T cell activation, and its expression on CD8(+)Foxp3(+) T cells is required for their suppressive capacity. In this study, we show that PD-1 signaling is required for the maintenance of functional regulatory CD4(+)CD25(+)Foxp3(+) regulatory T cells (CD4(+) T(reg)) that can control autoimmunity in (New Zealand Black × New Zealand White)F1 lupus mice. PD-1 signaling induced resistance to apoptosis and prolonged the survival of CD4(+) T(reg). In vivo, the blockade of PD-1 with a neutralizing Ab reduced PD-1 expression on CD4(+) T(reg) (PD1(lo)CD4(+) T(reg)). PD1(lo)CD4(+) T(reg) had an increased ability to promote B cell apoptosis and to suppress CD4(+) Th as compared with CD4(+) T(reg) with elevated PD-1 expression (PD1(hi)CD4(+) T(reg)). When PD-1 expression on CD4(+) T(reg) was blocked in vitro, PD1(lo)CD4(+) T(reg) suppressed B cell production of IgG and anti-dsDNA Ab. Finally, in vitro studies showed that the suppressive capacity of CD4(+) T(reg) depended on PD-1 expression and that a fine-tuning of the expression of this molecule directly affected cell survival and immune suppression. These results indicate that PD-1 expression has multiple effects on different immune cells that directly contribute to a modulation of autoimmune responses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23636058      PMCID: PMC3700538          DOI: 10.4049/jimmunol.1202382

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

1.  Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Science       Date:  2003-01-16       Impact factor: 47.728

Review 2.  Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity.

Authors:  Lieping Chen
Journal:  Nat Rev Immunol       Date:  2004-05       Impact factor: 53.106

3.  Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells.

Authors:  Takekazu Kubo; Robin D Hatton; James Oliver; Xiaofen Liu; Charles O Elson; Casey T Weaver
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

4.  Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFbeta-secreting CD8+ T cell suppressors.

Authors:  Bevra H Hahn; Ram Pyare Singh; Antonio La Cava; Fanny M Ebling
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

5.  Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcgammaRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE.

Authors:  J Rönnelid; A Tejde; L Mathsson; K Nilsson-Ekdahl; B Nilsson
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

6.  Ig-reactive CD4+CD25+ T cells from tolerized (New Zealand Black x New Zealand White)F1 mice suppress in vitro production of antibodies to DNA.

Authors:  Antonio La Cava; Fanny M Ebling; Bevra H Hahn
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

7.  T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus.

Authors:  R R Singh; V Kumar; F M Ebling; S Southwood; A Sette; E E Sercarz; B H Hahn
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

8.  Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis.

Authors:  Alan D Salama; Tanuja Chitnis; Jaime Imitola; Mohammed Javeed I Ansari; Hisaya Akiba; Fumihiko Tushima; Miyuki Azuma; Hideo Yagita; Mohamed H Sayegh; Samia J Khoury
Journal:  J Exp Med       Date:  2003-07-07       Impact factor: 14.307

9.  CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.

Authors:  A M Thornton; E M Shevach
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

10.  Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells.

Authors:  Sayuri Yamazaki; Tomonori Iyoda; Kristin Tarbell; Kara Olson; Klara Velinzon; Kayo Inaba; Ralph M Steinman
Journal:  J Exp Med       Date:  2003-07-21       Impact factor: 14.307

View more
  28 in total

1.  Autoimmunity and Cancer, the Paradox Comorbidities Challenging Therapy in the Context of Preexisting Autoimmunity.

Authors:  Julio C Valencia; Nkolika Egbukichi; Rebecca A Erwin-Cohen
Journal:  J Interferon Cytokine Res       Date:  2018-12-18       Impact factor: 2.607

Review 2.  Potential roles of self-reactive T cells in autoimmunity: lessons from cancer immunology.

Authors:  Mads Hald Andersen
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 3.  Co-stimulatory and co-inhibitory pathways in cancer immunotherapy.

Authors:  Rachel E O'Neill; Xuefang Cao
Journal:  Adv Cancer Res       Date:  2019-04-17       Impact factor: 6.242

Review 4.  Tregs in SLE: an Update.

Authors:  Antonio La Cava
Journal:  Curr Rheumatol Rep       Date:  2018-02-21       Impact factor: 4.592

Review 5.  A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity.

Authors:  Prabhakaran Kumar; Palash Bhattacharya; Bellur S Prabhakar
Journal:  J Autoimmun       Date:  2018-08-31       Impact factor: 7.094

Review 6.  Co-stimulatory and Co-inhibitory Pathways in Autoimmunity.

Authors:  Qianxia Zhang; Dario A A Vignali
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

7.  Higher Frequency and Increased Expression of Molecules Associated with Suppression on T Regulatory Cells from Newborn Compared with Adult Nonhuman Primates.

Authors:  Beth C Holbrook; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2020-09-02       Impact factor: 5.422

8.  Plasmodium vivax Infection Impairs Regulatory T-Cell Suppressive Function During Acute Malaria.

Authors:  Pedro A C Costa; Maria M Figueiredo; Suelen Q Diniz; Ana P M M Peixoto; Kevin J Maloy; Andréa Teixeira-Carvalho; Mauro S Tada; Dhelio B Pereira; Ricardo T Gazzinelli; Lis R V Antonelli
Journal:  J Infect Dis       Date:  2018-09-08       Impact factor: 7.759

Review 9.  Immune checkpoint receptors in regulating immune reactivity in rheumatic disease.

Authors:  Sabrina Ceeraz; Elizabeth C Nowak; Christopher M Burns; Randolph J Noelle
Journal:  Arthritis Res Ther       Date:  2014       Impact factor: 5.156

10.  Inflammation Determines the Capacity of Allogenic Endothelial Cells to Regulate Human Treg Expansion.

Authors:  Amy Rachael Cross; Julien Lion; Karine Poussin; Denis Glotz; Nuala Mooney
Journal:  Front Immunol       Date:  2021-07-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.